Used in pharmaceutical research as a key intermediate for synthesizing central nervous system agents. Shows potential in the development of antidepressants and antipsychotic drugs due to its structural affinity for monoamine receptors. Also explored for use in treatments targeting cognitive disorders and neurodegenerative diseases. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies involving piperidine-based bioactive molecules.